Time-Driven Activity-BasedCosting Analysis of Panretinal Photocoagulation
Open Access
- 15 January 2025
- journal article
- Published by Elsevier in Ophthalmology Retina
- Vol. 9 (5) , 498-501
Abstract
No abstract availableKeywords
Funding Information
- Vanderbilt Eye Institute
- Research to Prevent Blindness
This publication has 6 references indexed in Scilit:
- Time-driven Activity-based Costing Analysis of Fluorescein AngiographyOphthalmology Retina, 2023
- Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic RetinopathyJAMA Ophthalmology, 2021
- Anti–Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic RetinopathyOphthalmology Retina, 2021
- Diabetic Retinopathy Preferred Practice Pattern®Ophthalmology, 2020
- Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic RetinopathyJAMA Ophthalmology, 2019
- Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth FactorOphthalmology, 2019